Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Cholangiocarcinoma × sintilimab × Clear all

Phase

Status

Sponsor Class

OTHER 5 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2 Neoplasm Metastasis 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Cancer Liver Metastasis 1 Cholangiocarcinoma 1

Interventions

Gemcitabine 2 Everolimus 2 sintilimab 1 S 1 (combination) 1 Radiofrequency Ablation 1 Radiation 1 Neoadjuvant Therapy 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Congresses as Topic 1 Capecitabine 1 Ambulatory Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05207735 2022-01-26

SCRCA

Henan Cancer Hospital

Phase 2 Unknown

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡